The decreased expression of chemerin in murine and human melanomas was associated with a poor prognosis, suggesting an impaired anti-tumor NK cell recruitment in the background, which can be observed in the tumor microenvironment, aggravating the disease [229,230]. The gene discussed is RARRES2; the disease is neoplasm.